HERE FOR 20 YEARS FOR PEOPLE WITH AN INTEREST IN MULTIPLE SCLEROSIS Skip to content
MS Speaks
Login Register
Pages: [1]
0 Members and 0 Guests are viewing this board.
A

Positioning siponimod and the post-treatment gap: Unmet needs of SPMS patients...

Started by agate
1Replies
214Views
A
agate
A

(Abst.) Safety and tolerability of conversion fo siponimod from other DMTs...

Started by agate
0Replies
235Views
A
agate
A

Discovery may help reduce MS drug side effects

Started by agate
0Replies
346Views
A
agate
A

More skin cancer reported to FDA from patients on certain oral DMTs

Started by agate
0Replies
286Views
A
agate
A

(Abst.) Siponimod for MS

Started by agate
0Replies
263Views
A
agate
A

(Abst.) Are disease-modifying drugs for progressive MS worthwhile?

Started by agate
0Replies
250Views
A
agate
A

Turning thumbs down on Mayzent for NHS England

Started by agate
0Replies
233Views
A
agate
A

Siponimod and liver injury research information (PubMed)

Started by agate
0Replies
276Views
A
agate
A

Woman w/SPMS in Australia unable to get siponimod, turns to GoFundMe

Started by agate
0Replies
397Views
A
agate
A

Mayzent (siponimod, BAF312) for active SPMS, RRMS

Started by agate
14Replies
2908Views
A
agate

 

Pages: [1]